Vaccine Delivery Devices Market Size Forecast 2022-2027 | Industry Analysis, Report, Share, Growth, Trends
The global vaccine delivery devices market size reached US$ 6.44 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 10.23 Billion by 2027 exhibiting a growth rate (CAGR) of 7.80% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
A vaccine refers to a biological substance used for protecting individuals from bacterial diseases by stimulating the immune response of the body against them. It assists in producing antibodies against the invading antigens when given at specific intervals. A vaccine can be delivered to the body via microspheres, liposomes, micellar systems, immune stimulating complexes (ISCOMs), dendrimers, plant-derived viruses, etc. As such, vaccine delivery devices are extensively utilized in hospitals and clinics.
Request free sample brochure: https://www.imarcgroup.com/vaccine-delivery-devices-market/requestsample
Vaccine Delivery Devices Market Trends and Drivers:
The expanding healthcare sector, owing to the easy access to medical products and services, is primarily driving the vaccine delivery devices market. Additionally, the widespread adoption of needle-free delivery systems as they decrease needle stick injuries as well as vaccine antigen dose and enhance the vaccine immunogenicity is further catalyzing the market growth.
Apart from this, the leading manufacturers are also focusing on using novel delivery technologies that increase the therapeutic value of vaccines by reducing toxicity, which is acting as another significant growth-inducing factor. Moreover, numerous advancements in the systematic delivery of vaccines, such as the introduction of micro-needles and electroporation, and the launch of immunization programs by government bodies to prevent disabilities and deaths from vaccine-preventable diseases, are positively influencing the global market.
Besides this, the growing prevalence of chronic disorders and the sudden outbreak of the COVID-19 pandemic are anticipated to fuel the vaccine delivery devices market over the forecasted period.
Vaccine Delivery Devices Market Report Scope | |
| Report Coverage | Details |
| Market size value in 2021 | US$ 6.44 Billion |
| Market forecast in 2027 | US$ 10.23 Billion |
| Growth Rate | CAGR of 7.80% from 2022 to 2027 |
| Base year for estimation | 2021 |
| Historical data | 2016-2021 |
| Forecast period | 2022-2027 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Device, Route of Administration and End User |
| Regional scope | North America, Europe, Asia-Pacific, Latin America, Middle East and Africa |
| Key companies profiled | 3M Company, Becton Dickinson and Company, Enesi Pharma Limited, Gerresheimer AG, INOVIO Pharmaceuticals, NanoPass, Panacea Biotec Pharma Limited (Panacea Biotec), Pharmajet Inc., Schott AG (Carl-Zeiss-Stiftung), Terumo Corporation and Vaxxas. |
| Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
| Customization preview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Device:
- Syringes
- Jet Injectors
- Others
Breakup by Route of Administration:
- Intramuscular Vaccination
- Intradermal Vaccination
- Subcutaneous Vaccination
- Others
Breakup by End User:
- Hospitals
- Clinics
- Others
By Geography:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
List of Major Key Players:
The major players in the market are
- 3M Company
- Becton Dickinson and Company
- Enesi Pharma Limited
- Gerresheimer AG
- INOVIO Pharmaceuticals
- NanoPass
- Panacea Biotec Pharma Limited (Panacea Biotec)
- Pharmajet Inc.
- Schott AG (Carl-Zeiss-Stiftung)
- Terumo Corporation
- Vaxxas.
Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/vaccine-delivery-devices-market
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Other Related Report:
Anesthesia and Respiratory Devices Market 2022-2027: https://www.imarcgroup.com/anesthesia-respiratory-devices-market
Home Medical Equipment Market Share: https://www.imarcgroup.com/home-medical-equipment-market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
